Page last updated: 2024-11-06

salsoline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

salsoline: monomethylated metabolite of salsolinol; endogenous neurotoxin found in CSF of patients with Parkinson's disease [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID46695
CHEMBL ID1532461
CHEBI ID110170
SCHEMBL ID1009940
MeSH IDM0102190

Synonyms (50)

Synonym
BRD-A48323445-001-02-6
7-methoxy-1-methyl-1,2,3,4-tetrahydro-isoquinolin-6-ol
DIVK1C_006710
7-methoxy-1-methyl-1,2,3,4-tetrahydroisoquinolin-6-ol
SDCCGMLS-0066795.P001
SPECTRUM4_001951
SPECTRUM_001463
SPECTRUM5_000887
CBDIVE_000261
BSPBIO_002846
salsoline
NCGC00095326-01
KBIO2_007079
KBIO2_004511
KBIO2_001943
KBIOSS_001943
KBIOGR_002385
KBIO1_001654
KBIO3_002066
SPECTRUM2_000540
SPBIO_000559
SPECTRUM3_001113
SPECPLUS_000614
OPREA1_746478
CHEBI:110170
AKOS000277328
76419-97-1
A26194
CHEMBL1532461
CCG-38721
NCGC00017168-02
SCHEMBL1009940
AKOS016038403
7-methoxy-1-methyl-1,2,3,4-tetrahydro-6-isoquinolinol #
(+,-)-salsoline
HMS3561B13
Q27189551
7-methoxy-1-methyl-1,2,3,4-tetrahydroisoquinoline-6-ol
mfcd00056096
6-hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydroisoquinoline
7-methoxy-1-methyl-1,2,3,4-tetrahydro-6-isoquinolinol, aldrichcpr
FT-0773993
FT-0758953
BRD-A48323445-001-03-4
(-)-(s)-salsoline;(-)-salsoline
BCP30496
PS-0261
DTXSID80871573
CS-0283074
EN300-186634
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
isoquinolinesA class of organic heteropolycyclic compound consisting of isoquinoline and its substitution derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency3.16230.011212.4002100.0000AID1030
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (50)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (6.00)18.7374
1990's18 (36.00)18.2507
2000's21 (42.00)29.6817
2010's7 (14.00)24.3611
2020's1 (2.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews6 (10.17%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other53 (89.83%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]